What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies.
Posts Tagged ‘Baker Bros. Advisors’
This Metric Says You Are Smart to Sell Ariad Pharmaceuticals, Inc. (ARIA)
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age.
Is Salix Pharmaceuticals, Ltd. (SLXP) Going to Burn These Hedge Funds?
In the 21st century investor’s toolkit, there are dozens of methods shareholders can use to monitor their holdings.
What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up
In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.
Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)
In the financial world, there are dozens of gauges shareholders can use to analyze stocks. Two of the most under-the-radar are hedge fund and insider trading sentiment.
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling
If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age.
ChemoCentryx Inc (CCXI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
ChemoCentryx Inc (NASDAQ:CCXI) was in 6 hedge funds' portfolio at the end of March. CCXI has experienced an increase in enthusiasm from smart money recently.
Hedge Funds Are Crazy About Ligand Pharmaceuticals Inc. (LGND)
At the moment, there are dozens of methods investors can use to monitor the equity markets. Some of the most useful are hedge fund and insider trading interest.
This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)
Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm from smart money lately.
Do Hedge Funds and Insiders Love Cerus Corporation (CERS)?
In today’s marketplace, there are a multitude of indicators market participants can use to watch stocks.
XenoPort, Inc. (XNPT): Hedge Funds and Insiders Are Bearish, What Should You Do?
Is XenoPort, Inc. (NASDAQ:XNPT) a healthy stock for your portfolio? Money managers are in a pessimistic mood.
Synageva BioPharma Corp (GEVA): Hedge Funds and Insiders Are Bullish, What Should You Do?
In the 21st century investor’s toolkit, there are tons of indicators investors can use to track stocks. Some of the most useful are hedge fund and insider trading activity.
Do Hedge Funds and Insiders Love AVEO Pharmaceuticals, Inc. (AVEO)?
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was in 9 hedge funds' portfolio at the end of the first quarter of 2013.
Geron Corporation (GERN): Are Hedge Funds Right About This Stock?
To most investors, hedge funds are assumed to be worthless, old investment tools of the past.
Hedge Funds Are Betting On Kythera Biopharmaceuticals Inc (KYTH)
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds' portfolio at the end of March.
Here is What Hedge Funds Think About Insmed Incorporated (INSM)
Insmed Incorporated (NASDAQ:INSM) was in 11 hedge funds' portfolio at the end of March. INSM shareholders have witnessed an increase in enthusiasm from smart money of late.
Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds' portfolio at the end of March.
Do Hedge Funds and Insiders Love Geron Corporation (GERN)?
According to most stock holders, hedge funds are perceived as underperforming, old investment vehicles of the past.
Do Hedge Funds and Insiders Love Ligand Pharmaceuticals Inc. (LGND)?
If you'd ask most investors, hedge funds are seen as slow, old financial tools of yesteryear.
Derma Sciences Inc (DSCI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
At the moment, there are a multitude of indicators investors can use to watch their holdings. Some of the best are hedge fund and insider trading movement.
Do Hedge Funds and Insiders Love ZIOPHARM Oncology Inc. (ZIOP)?
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) was in 6 hedge funds' portfolio at the end of December.
Do Hedge Funds and Insiders Love Synageva BioPharma Corp (GEVA)?
At the moment, there are dozens of metrics shareholders can use to watch publicly traded companies. A couple of the most useful are hedge fund and insider trading activity.
Do Hedge Funds and Insiders Love Discovery Laboratories, Inc. (DSCO)?
Is Discovery Laboratories, Inc. (NASDAQ:DSCO) the right pick for your portfolio? Hedge funds are becoming less confident.
Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?
Is Seattle Genetics, Inc. (NASDAQ:SGEN) a healthy stock for your portfolio? The smart money is in a pessimistic mood.
Hedge Funds Are Dumping QLT Inc. (USA) (QLTI) – Sequenom, Inc. (SQNM), Idenix Pharmaceuticals Inc (IDIX)
To most investors, hedge funds are seen as slow, outdated financial vehicles of yesteryear.
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock? – Merrimack Pharmaceuticals Inc (MACK), TESARO Inc (TSRO)
To most stock holders, hedge funds are perceived as worthless, old financial vehicles of years past.
This Metric Says You Are Smart to Buy Progenics Pharmaceuticals, Inc. (PGNX) – Cerus Corporation (CERS), XOMA Corp (XOMA)
In the eyes of most shareholders, hedge funds are assumed to be underperforming, outdated financial tools of yesteryear.
Should You Avoid BioDelivery Sciences International, Inc. (BDSI)? – ArQule, Inc. (ARQL), Amicus Therapeutics, Inc. (FOLD)
In today’s marketplace, there are tons of metrics shareholders can use to watch the equity markets. Some of the most underrated are hedge fund and insider trading interest.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA): Insiders Are Dumping, Should You?
Is Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) a healthy stock for your portfolio? Money managers are reducing their bets on the stock.
Array Biopharma Inc (NASDAQ:ARRY): Are Hedge Funds Right About This Stock?
If you'd ask most stock holders, hedge funds are seen as worthless, old investment tools of years past.
Pharmacyclics, Inc. (NASDAQ:PCYC): Are Hedge Funds Right About This Stock?
Is Pharmacyclics, Inc. (NASDAQ:PCYC) a healthy stock for your portfolio? Investors who are in the know are becoming hopeful.
Insiders Have Bought Alcoa, Darden, and More This Year
We track insider purchases filed with the SEC because, in contrast to insider sales (which can often occur merely because an insider is rationally diversifying away from their...
A Synageva Board Member’s Trusts Bought Shares
Trusts related to Board of Directors member Thomas Tisch purchased about 21,000 shares of Synageva Biopharma Corp (NASDAQ:GEVA) on January 9th at an average price of $47.53 per...
Best Hedge Funds in 2012
Insider Monkey looks for long/short equity hedge funds with the best stock picking ability. The reason is simple.
